SavedAdd your journal

Journals / Türk Psikiyatri Dergisi / 2011 / Cilt: 22 - Sayı: 3

Galactorrhea during duloxetine treatment: a case report

Duloksetin tedavisi sırasında gelişen galaktore: Olgu sunumu

SEVDA KORKMAZ
Murat KULOĞLU
Umut IŞIK
Sadullah SAĞLAM
MURAD ATMACA
Pages
200–201
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Herein we report a hyperprolactinemia case with galactorrhea due to duloxetine treatment for depression.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:High prolactin hormone level in the blood is known as hyperprolactinemia.
📊
Key Findings & Data:The most common symptom of hyperprolactinemia is galactorrhea, in which spontaneous milky discharge is seen from all ducts of the 2 mammary glands.
💡
Conclusion & Impact:Herein we report a hyperprolactinemia case with galactorrhea due to duloxetine treatment for depression.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

High prolactin hormone level in the blood is known as hyperprolactinemia. The most common symptom of hyperprolactinemia is galactorrhea, in which spontaneous milky discharge is seen from all ducts of the 2 mammary glands. Galactorrhea occurs due to different medical conditions, including the use of antidepressant medications. Herein we report a hyperprolactinemia case with galactorrhea due to duloxetine treatment for depression.

Özet

Kandaki prolaktin hormonu düzeyinin yüksek olması hiperprolaktinemi olarak adlandırılır. Hiperprolaktineminin en sık görülen belirtisi, her iki memenin, tüm kanallarından spontan sütlü akıntı gelmesi olarak tanımlanan galaktoredir. Galaktore, pek çok tıbbi duruma bağlı olarak ortaya çıkabildiği gibi antidepresanların da içinde bulunduğu birçok ilacın kullanımıyla da karşılaşılabilen klinik bir tablodur. Bu yazıda depresif bozukluk tanısıyla duloksetin tedavisi almakta iken hiperprolaktinemi ve galaktore ortaya çıkan bir olgu sunulmuştur.

🔖

Cite This Article

KORKMAZ, S., KULOĞLU, M., IŞIK, U., SAĞLAM, S., ATMACA, M. (2011). Galactorrhea during duloxetine treatment: a case report. Türk Psikiyatri Dergisi, Cilt: 22 - Sayı: 3, 200–201. https://ajindex.com/articles/89106

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Ashton AK, Longdon MC (2007) Hyperprolactinemia and galactorrhea induced by serotonin and norepinephrine reuptake inhibiting antidepressants. Am J Psychiatry, 164: 1121-2.
  2. Bronzo MR, Stahl SM (1993) Galactorrhea induced by sertraline (letter). Am J Psychiatry, 150: 1269-70.
  3. Checkley S (1991) Neuroendocrine effects of psychotropic drugs. Baillière’s Clinical Endocrinology and Metabolism, 5: 15-33.
  4. Colao A, Lombardi G, Annunziato I (2000) Cabergoline. Expert Opin Pharmacother, 2000; 1:555-5574.
  5. Cooper DS, Gelenberg AJ, Wojcik JC ve ark. (1981) The effect of amoxapine and imipramine on serum prolactin levels. Ann Intern Med, 141: 1023-25.
  6. Çorapçıoğlu A, Aydemir Ö, Yıldız M ve ark. (1999) DSM-IV Eksen I Bozuklukları (SCID-I) için Yapılandırılmış Klinik Görüşme, Klinik Versiyon. Ankara:
  7. Hekimler Yayın Birliği. Edge DS, Segatore M (1993) Assessment and management of galactorrhea. Nurse Pract, 18: 3549. Feuchtl A, Bagli M, Stephan R ve ark. (2004) Pharmacokinetics of m-chlorophenylpiperazine after intravenous and oral administration in healthy male volunteers: implication for the pharmacodynamic profile, Pharmacopsychiatry, 37: 180-8.
  8. Halbreich U, Kinon BJ, Gilmore JA ve ark. (2003) Elevated prolactin levels in patients with schizophrenia: mechanisms and related adverse effects. Psychoneuroendocrinology, 28(suppl1): 53-67.
  9. Peterson MC (2001) Reversible galactorrhea and prolactin elevation related to fluoxetine use. Mayo Clin Proc, 76: 215-6.
  10. Reichlin S (1985) Neuroendocrinology. In: Wilson JD, Foster DW, eds. Textbook of Endocrinology, 7th ed. Philadelphia: Saunders, 492-567.
  11. Spigset O, Mjorndal T (1997) The effect of fluvoxamine on serum prolactin and serum sodium concentrations: relation to platelet 5-HT2A receptor status. J Clin Psychopharmacol, 17: 292-7.
  12. Webster J, Piscitelli G, Polli A ve ark. (1993) The efficacy and tolerability of long-term cabergoline therapy in hyperprolactinemic disorders: an open, uncontrolled, multicentre study. Clin Endocrinol, 39: 323-9.
  13. Wieck A, Haddad PM (2003) Antipsychotic-induced hyperprolactinaemia in women: pathophysiology, severity and consequences. Br J Psychiatry, 182: 199-204.
  14. Yang MS, Cheng WJ, Huang MC (2009) Dose-related hyperprolactinemia induced by venlafaxine. Prog Neuropsychopharmacol Biol Psychiatry, 33: 733-4.